Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis

References

• Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: A population-based study. J Thromb Haemost. 2007; 5(4):692–9.
   PubMed Web of Science ®Google Scholar
• Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep venous thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19–25.
   PubMed Web of Science ®Google Scholar
• Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Predictor of survival after deep venous thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med. 1999;159(5):445–53.
   PubMed Web of Science ®Google Scholar
• Hawbaker S. Venous thromboembolism in the cancer population: Pathology, risk, and prevention. J Adv Pract Oncol. 2012;3(1):23–33.
   PubMedGoogle Scholar
• Ungprasert P, Srivali N, Wijarnpreecha K, Charoenpong P, Knight EL. Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: A systematic review and meta-analysis. Rheumatology (Oxford). 2014;55(4);736–42
   Google Scholar
• Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees. Thromb Res. 2015;135(1):50–7.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Sanguankeo A. Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis. Rheumatol Int. 2014;34(10):1455–8.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Sanguankeo A, Upala S, Suksaranjit P. Psoriasis and risk of venous thromboembolism: A systematic review and meta-analysis. QJM. 2014;107(10):793–7.
   PubMed Web of Science ®Google Scholar
• Tomasson G, Monach PA, Merkel PA. Thromboembolic disease in vasculitis. Curr Opin Rheumatol. 2009;21(1):41–6.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Srivali N, Spanuchart I, Thongprayoon C, Knight EL. Risk of venous thromboembolism in patients with rheumatoid arthritis: A systematic review and meta-analysis. Clin Rheumatol. 2014;33(3):297–304.
   PubMed Web of Science ®Google Scholar
• Almeida I, Faria R, Vita P, Vasconcelos C. Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev. 2011;10(11):693–701.
   PubMed Web of Science ®Google Scholar
• Wells AU, Margaritopoulos GA, Antoniou KM, Denton C. Interstitial lung disease in systemic sclerosis. Semin Respir Crit Care Med. 2014;35(2):213–21.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: A systematic review and meta-analysis. Clin Rheumatol. 2014;33(8):1099–104.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Medicine. 2011;9:1.
   PubMed Web of Science ®Google Scholar
• Johannesdottir SA, Schmidt M, horvath-Puho E, Sørensen HT. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case–control study. J thromb haemost. 2012;10(5):815–21.
   PubMed Web of Science ®Google Scholar
• Zoller B, Li X, Sunquist J, Sunquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379(9812):244–9.
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta JA, Hemmati I, Sayre EC, et al. The risk of pulmonary embolism and deep vein thrombosis in systemic sclerosis: A population based study. Presented at the American college of rheumatology annual scientific meeting. 25–30 October 2013, San Diego, California. [Abstract number 1814].
   Google Scholar
• Chung WS, Lin CL, Sung FC, Hsu WH, Yang WT, Lu CC, Kao CH. Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: A nationwide cohort study. Rheumatology (Oxford). 2014;53(9):1639–45.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986;7(3):177–88.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, et al. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol. 2011;38(9):1931–9.
   PubMed Web of Science ®Google Scholar
• Gupta R, Thaba MM, Gupta S, Shankar S, Kumar A. Clinical significance of antiphospholipid antibodies in Indian scleroderma patients. Rheumatol Int. 2009;30(2):277–9.
   PubMed Web of Science ®Google Scholar
• Sanna G, Bertolaccini ML, Mameli A, Hughes G, Khamashta M, Mathieu A. Antiphospholipid antibodies in patients with scleroderma: Prevalence and clinical significance. Ann Rheum Dis. 2005; 64(12):1795–6.
   PubMed Web of Science ®Google Scholar
• Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie. 2010;30(1):5–6, 8–9.
   PubMed Web of Science ®Google Scholar
• Nagareddy P, Smyth SS. Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol. 2013;20(5):457–63.
   PubMed Web of Science ®Google Scholar
• Silvarino R, Danza A, Merola V, Berez A, Mendez E, Espinosa G, Cervera R. Venous thromboembolic disease in systemic autoimmune diseases: An association to keep in mind. Autoimmune Rev. 2012;12(2):289–94.
   PubMed Web of Science ®Google Scholar
• Montecucco F, Mach F. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford). 2009;48(1):11–22.
   PubMed Web of Science ®Google Scholar
• Biasillio G, Leo M, Della Bona R, Marzio Biasucci L. Inflammatory bio-marker and coronary artery disease: from bench to bedside and back. Intern Emerg Med. 2010;5(3):225–33.
   PubMed Web of Science ®Google Scholar
• Jezovnik MK, Poredos P. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol. 2010; 29(3):226–31.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Sanguankeo A, Upala S, Knight EL. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(3):366–70.
   PubMed Web of Science ®Google Scholar